Dana Investment Advisors’s Ampio Pharmaceuticals Inc. AMPE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-217
Closed -$4K 425
2022
Q3
$4K Hold
217
﹤0.01% 397
2022
Q2
$11K Hold
217
﹤0.01% 411
2022
Q1
$31K Hold
217
﹤0.01% 341
2021
Q4
$37K Hold
217
﹤0.01% 328
2021
Q3
$108K Hold
217
﹤0.01% 314
2021
Q2
$109K Hold
217
﹤0.01% 315
2021
Q1
$110K Hold
217
0.01% 313
2020
Q4
$103K Hold
217
0.01% 296
2020
Q3
$62K Hold
217
﹤0.01% 280
2020
Q2
$41K Hold
217
﹤0.01% 259
2020
Q1
$27K Buy
+217
New +$39.3K ﹤0.01% 268

Other funds holding AMPE

Dana Investment Advisors's AMPE Position: Q4 2022 in Review

Dana Investment Advisors sold out of Ampio Pharmaceuticals Inc. (AMPE) in Q4 2022, closing a stake of 217 shares — an estimated $4K sold.

Dana Investment Advisors first reported a position in AMPE in Q1 2020 and held it in 11 quarters. The position peaked at $110K in Q1 2021. 32 funds tracked by Wall St. Rank hold AMPE as of Q4 2022.

  • Dana Investment Advisors reported no remaining Ampio Pharmaceuticals Inc. position as of Q4 2022 after selling out during the quarter.
  • Dana Investment Advisors sold 217 Ampio Pharmaceuticals Inc. shares in Q4 2022, an estimated $4K.
  • Dana Investment Advisors first reported a position in Ampio Pharmaceuticals Inc. in Q1 2020 and held it in 11 quarters.
  • Dana Investment Advisors's Ampio Pharmaceuticals Inc. position peaked at $110K in Q1 2021.
  • 32 funds tracked by Wall St. Rank held Ampio Pharmaceuticals Inc. as of Q4 2022.

Based on Dana Investment Advisors's 13F filing for Q4 2022, filed 13 Feb 2023.